Transformative mutation specific pharmacotherapy for cystic fibrosis

BMJ. 2012 Jan 9:344:e79. doi: 10.1136/bmj.e79.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aminophenols / therapeutic use*
  • Cystic Fibrosis / drug therapy*
  • Cystic Fibrosis / genetics*
  • Cystic Fibrosis / physiopathology
  • Forced Expiratory Volume
  • Humans
  • Mutation*
  • Quinolones / therapeutic use*

Substances

  • Aminophenols
  • Quinolones
  • ivacaftor